FdaApplication
NDA 021964
Identifiers
- fda_app_no: NDA021964
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2008-04-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RELISTOR | METHYLNALTREXONE BROMIDE | 8MG/0.4ML (8MG/0.4ML) | SOLUTION;SUBCUTANEOUS |
| RELISTOR | METHYLNALTREXONE BROMIDE | 12MG/0.6ML (12MG/0.6ML) | SOLUTION;SUBCUTANEOUS |
| RELISTOR | METHYLNALTREXONE BROMIDE | 12MG/0.6ML (12MG/0.6ML) | SOLUTION;SUBCUTANEOUS |
3 products